Over 13,000 Cases in 2025, Fourth Consecutive Year of High Infection Rates

Japan is experiencing a dramatic surge in syphilis infections. According to the Japan Institute of Health and Crisis Management (JIHS), as of December 21, 2025, new syphilis cases in Japan reached 13,294. This represents a more than tenfold increase from the 1,228 cases reported in 2013.

Just a decade ago, syphilis was considered a nearly eradicated rare disease in Japan. However, infection rates began climbing sharply from 2013, surpassing 10,000 cases for the first time in 2022. In 2023, cases exceeded 15,000, marking an all-time high.

While the figures for 2024 and 2025 show a slight decline from 2023, they remain above 13,000, indicating that the high-risk situation continues. A Japanese infectious disease expert expressed concern, calling syphilis "a re-emerging infectious disease in Japan."

Young Women in Their 20s and Men Across All Age Groups Are Primary Infection Demographics

The gender and age distribution of infected individuals reveals distinct patterns. Male infections account for approximately two-thirds of all cases, with increases observed across all age groups from their 20s to 60s.

In contrast, female infections are concentrated among those in their 20s. Notably, the rate of increase among women far exceeds that of men. Female infection cases, which numbered 235 in 2013, have surged more than twentyfold, exceeding 5,000 in each of the past three years.

The situation in major cities like Tokyo is even more severe. In 2023, male syphilis patients in Tokyo increased ninefold compared to a decade earlier, while female patients skyrocketed by 40 times.

Dating Apps and Sex Industry Expansion Identified as Primary Causes

Japanese public health experts point to dating apps popular among younger demographics as a major driver of syphilis transmission. In an interview with the Asahi Shimbun, one infectious disease specialist noted that "these platforms have significantly increased opportunities for sexual contact with multiple partners and heightened the possibility of high-risk sexual behavior."

A study titled "Association Between Dating App Use and Syphilis Incidence in Japan" found a significant positive correlation between dating app prevalence and syphilis infection rates, with correlations being stronger among female populations. Researchers recommended that future studies on sexually transmitted disease transmission mechanisms and prevention should incorporate social media usage data.

The developed sex industry is also cited as a major contributor to rising infection rates. According to data released by Japan's Ministry of Health, Labour and Welfare, the percentage of individuals reporting a history of sex work involvement is 30-40% among women, while among male consumers, the rate has exceeded 40% since the fourth quarter of 2022 and continues to rise.

Lack of Awareness and Delayed Diagnosis Create a Vicious Cycle

Another significant problem is that many patients delay seeking treatment due to lack of awareness about syphilis and social stigma. According to the Yomiuri Shimbun, many infected individuals only visit hospitals when obvious symptoms such as severe rashes or ulcers appear, or when the disease reaches advanced stages affecting the nervous or cardiovascular systems.

One clinician explained, "The chancre of primary syphilis is painless, so many patients mistake it for a common skin issue and only seek medical care when secondary symptoms like systemic rashes or joint pain appear."

Such diagnostic delays not only complicate individual treatment but also significantly increase the risk of unknowingly transmitting the infection to partners.

The Ministry of Health, Labour and Welfare consistently emphasizes "enhanced prevention and early medical consultation," recommending safe sexual practices and immediate testing when infection is suspected. While many public health centers offer free anonymous testing, and some provide evening/holiday testing or women-only testing days, persistently high new infection numbers suggest these preventive measures remain insufficient.

Historical Context: The Re-emergence of a Nearly Vanished Disease

Syphilis was a widespread sexually transmitted disease in the 20th century, but infection rates dropped dramatically with the widespread use of penicillin. Japan has maintained a syphilis reporting system since 1948, with cases declining steadily after peaking at approximately 11,000 in 1967.

By the early 2000s, syphilis in Japan appeared nearly eradicated. However, the situation reversed starting in 2013, and from 2021 onward, infections increased explosively, earning syphilis the new designation of "re-emerging infectious disease."

This pattern is not unique to Japan. According to the U.S. Centers for Disease Control and Prevention (CDC), syphilis cases in the United States exceeded 207,000 in 2022, the highest level since 1950. Congenital syphilis cases increased 937% compared to 2018, resulting in 282 stillbirths and infant deaths.

The World Health Organization (WHO) estimates approximately 12 million new syphilis infections occur globally each year and has set a goal to reduce annual new sexually transmitted infections among the 15-49 age population to under 150 million by 2030.

Future Outlook [AI Analysis]

A short-term reversal of Japan's syphilis infection trend appears unlikely. Structural factors such as dating apps and the sex industry remain operational, and significant time is needed to improve social awareness and establish an early screening culture.

However, the declining trend since the 2023 peak may be a positive signal. Continuous public health campaigns and expanded free testing may be having some effect.

Meanwhile, treatment supply issues present another variable. Benzathine penicillin, the first-line medication for syphilis treatment, faces supply shortages in several countries. In July 2025, the U.S. CDC issued an urgent letter to healthcare providers recommending "prioritizing use for pregnant syphilis patients."

Early diagnosis and treatment are crucial. Clinical experts emphasize that "most patients can achieve clinical cure after primary drug treatment" and that "establishing proper sexual awareness, avoiding unsafe sexual practices, and correct condom use remain the most effective preventive measures."

Anyone who has engaged in risky sexual behavior or experiences early symptoms should seek testing immediately. Syphilis is a treatable disease and can be completely cured, especially with standardized treatment in the early stages.